← FDA DRUG APPROVALS

FDA ANDA · ANDA080016

PROPYLTHIOURACIL

Sponsor: CHARTWELL MOLECULAR

APPLICATION
ANDA080016
TYPE
ANDA
ORIGINAL APPROVAL
1970-07-24
LATEST ACTION
1990-08-31
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PROPYLTHIOURACILDiscontinued
PROPYLTHIOURACIL 50MG · TABLET · ORAL

Approval history

1990-08-31Labeling · Supplement 9AP
1990-03-28Labeling · Supplement 8AP
1970-07-24OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →